• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: B.BRAUN MEDICAL SAS FRANCE CELSITE; ACCESS PORT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

B.BRAUN MEDICAL SAS FRANCE CELSITE; ACCESS PORT SYSTEM Back to Search Results
Model Number 4430095
Device Problems Crack (1135); Fracture (1260)
Patient Problem Swelling/ Edema (4577)
Event Date 10/27/2022
Event Type  malfunction  
Event Description
"description of event:on (b)(6) 2022, the patient was admitted to the hospital.On (b)(6) 2022, the infusion port was maintained to draw blood and pass fluid smoothly.The infusion process was smooth without special abnormalities.On (b)(6) 2022, the patient was found to have subcutaneous tissue swelling in the right neck and right chest during the infusion using the port.It was considered to be port catheter rupture.Color doppler ultrasonography was performed, and abnormal echo of the neck catheter was found.It was considered to be catheter rupture.Magnesium sulfate wet compress was given to the neck and chest, and the local edema subsided.On (b)(6) 2022, the venous access port was removed, the port body and catheter were completely removed, and 2 ruptures of the catheter were found.At present, the patient was in stable condition, picc catheter was implanted, and intravenous chemotherapy was performed, and the process went smoothly.This event was common liquid, which did not cause serious event; if it was chemotherapy drugs, it might cause permanent body damage.The patient developed subcutaneous swelling in the right neck and chest after port infusion, which was considered to be exudation caused by port catheter rupture.Color doppler ultrasound showed catheter rupture, which was confirmed to be catheter rupture after removal.Preliminary handling of event: 1.On (b)(6) 2022, the patient was found to have subcutaneous tissue swelling in the right neck and right chest during infusion of the port, which was considered to be port catheter rupture.Color doppler ultrasonography was performed, and abnormal echo of the neck catheter was found, which was considered to be catheter rupture.Magnesium sulfate wet compress was given to the neck and chest, and the local edema subsided.On (b)(6) 2022, the venous access port was removed, the port body and catheter were completely removed, and 2 ruptures of the catheter were found.At present, the patient was in stable condition, picc catheter was implanted, and intravenous chemotherapy was performed, and the process went smoothly.2.The relevant administrative department of the hospital rushed to the scene at the first time after receiving the report of this adverse event and found that the incident of port catheter rupture was true.In this event, the patient infused the infusion into a common liquid, which did not lead to a serious event.At the first time, the ruptured implantable drug delivery device port catheter removed from the patient was preserved for subsequent use to find the cause, and photographed and collected evidence to assist the department in tracing the consumables of this problem.After inquiring the batch number of the consumables and relevant information, the information and pictures were fed back to the supplier and manufacturer.".
 
Manufacturer Narrative
Batch history review: we have checked the manufacturing file of batch nr 36958054 which complies with our specifications and does not present any discrepancy.No other similar complaint was reported to us on this batch of access ports released in february 2020.Investigation results: we did not receive the complaint sample nor the x-ray pictures for investigation.Conclusion: without the complaint sample or the x-ray pictures for investigation, no thorough investigation is possible and we cannot conclude on the real cause of this incident.If new elements become available in the future, we will reopen this complaint.This is a known and rare incident; no corrective action is envisaged for the moment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELSITE
Type of Device
ACCESS PORT SYSTEM
Manufacturer (Section D)
B.BRAUN MEDICAL SAS FRANCE
30 avenue des temps modernes
chasseneuil du poitou 86360
FR  86360
Manufacturer (Section G)
B.BRAUN MEDICAL SAS FRANCE
30 avenue des temps modernes
chasseneuil du poitou, 86360
FR   86360
Manufacturer Contact
catherine boismenu
30 avenue des temps modernes
chasseneuil du poitou, 86360
FR   86360
MDR Report Key15948740
MDR Text Key308244544
Report Number9612452-2022-00055
Device Sequence Number1
Product Code LJT
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Other
Type of Report Initial
Report Date 12/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/09/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number4430095
Device Lot Number36958054
Was Device Available for Evaluation? No
Date Manufacturer Received11/15/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/17/2020
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
Patient SexFemale
-
-